BMY vs CLDX
BMY vs CLDX — side by side. Price, change, valuation.
BMY
Bristol-Myers Squibb Company
$62.56+0.76%
NYSE
CLDX
Celldex Therapeutics, Inc.
$35.65+1.05%
NasdaqCM
| Metric | BMY | CLDX | Side by side |
|---|---|---|---|
| Last price | $62.56 | $35.65 | +26.91 |
| Day Δ % | 0.76 | 1.05 | −0.29pp |
| Market cap | not on file | not on file | not on file |
| P/E (fwd) | not on file | not on file | not on file |
| Implied move | not on file | not on file | not on file |
| Put/Call OI | not on file | not on file | not on file |
| Analyst target (mean) | not on file | not on file | not on file |
Descriptor deltas are comparative facts (higher / lower), not a recommendation. A metric absent for either company is shown as “not on file” — never filled with a placeholder.